No Data
Private Equity Firms Who Own 45% Along With Institutions Invested in NeuroPace, Inc. (NASDAQ:NPCE) Saw Increase in Their Holdings Value Last Week
Earnings Preview: NeuroPace to Report Financial Results Post-market on November 12
$NeuroPace(NPCE.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $NeuroPace(NPCE.US)$ to post revenue of USD19.08M for 2024Q3, up 16.
Express News | Neuropace Announces FDA Submission of Three-Year Data From Post-Approval Study of the Rns System in Focal Epilepsy
NeuroPace Announces FDA Submission of Three-Year Data From Post-Approval Study of the RNS System in Focal Epilepsy
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20
Lake Street analyst Frank Takkinen maintains $NeuroPace(NPCE.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 46.9% and a
No Data
No Data